LabMed

Citrullinemia (CIT1)

At a Glance

Citrullinemia, most commonly known as Citrulliemia type 1 (CIT1), is an inherited disorder of urea cycle metabolism. Urea cycle disorders are a collection of 8 enzymes involved in waste nitrogen excretion as urea including N-acetylglutamate synthase deficiency (NAGS), carbamoylphosphate synthetase (CPS1), ornithine transcarbamylase deficiency (OTC), citrin deficiency (including citrullinemia type 2, CIT2), argininosuccinic acidemia (ASA), and argninase deficiency (ARG). All enzyme deficiencies, except ARG, may present with acute hyperammonemia.

CIT1 is due to a defect in argninosuccinic acid synthetase (ASS), which converts citrulline and aspartate into argninosuccinic acid. CIT1 is inherited in an autosomal recessive manner. Autosomal recessive inheritance means the individual has inherited 2 abnormal copies of the ASS gene (each gene contains a mutation). Both parents of an individual with CIT1 are carriers and do not manifest any symptoms of disease.

Individuals with CIT1 deficiency will exhibit symptoms similar to other urea cycle disorders with hyperammonemia. Infants may present in the first few days of life with hyperammonemia with increasing lethargy, poor feeding, vomiting or irritability, and tachypnea similar to sepsis. They may rapidly progress to respiratory alkalosis as ammonia increases with cerebral edema, seizures, loss of reflexes, hypothermia, apnea, and coma.

Infantile or childhood presentations include vomiting, irritability, and failure to thrive often triggered by illnesses. Infections, surgery, or other stressors that create a catabolic state may trigger later onset forms in older children, adolescents, or adults. These later onset presentations are often due to partial enzyme deficiencies and may not lead to severe, permanent brain damage and developmental delays often seen in early, more severe onset forms.

Other disorders that may present with hyperammonemia include liver failure, drug toxicity, or inherited organic acidemia, such as propionic acidemia or methylmalonic acidemia, that also have severe metabolic acidosis.

Elevations of citrulline are also seen in CIT2 due to citrin deficiency from mutations in the gene, SLC25A13. Citrin is a mitochondrial membrane associated aspartate glutamate transporter.

Citrin deficiency limits the activity of ASS through limitation of aspartate. Citrin deficiency may present in adults with acute episodes of hyperammonemia and neurological symptoms as seen in other urea cycle disorders along with fatty liver infiltration and fibrosis. Citrin deficiency may also present in the newborn period as neonatal intrahepatic cholestasis (NICCD) with a transient cholestasis, fatty liver infiltrate, and fibrosis with dysfunction. Additionally infants may have failure to thrive, hypoglycemia, and hemolytic anemia, but hyperammonemia is not commonly seen.

What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?

Hyperammonemia is seen in urea cycle disorders.

Urea cycle disorders, such as CIT1 deficiency, can be diagnosed by quantitative plasma amino acid analysis. Elevations of glutamine, alanine, asparagine, and citrulline (commonly elevated over 1000 µM in CIT1 and CIT2) are seen, whereas levels of arginine are decreased.

Urine organic acids may show a mild elevation of orotic acid, but more often the level of orotic acid is normal. Ammonia should be closely followed initially every 2-3 hours until levels are controlled through medical management or hemodialysis.

Ammonia should be closely followed, initially every 2-3 hours, until levels are controlled through medical management or hemodialysis.

Follow-up testing for the acutely ill patient in a hyperammonemic crisis requires serial monitoring of arterial ammonia, serum electrolytes, arterial blood gas, blood glucose, and other testing in an intensive care unit. A biochemical geneticist should be consulted for management and treatment. Ongoing follow-up testing will be determined upon the use of hemodialysis or intravenous infusion of nitrogen scavengers for alternate pathway removal of nitrogen such as sodium benzoate and sodium phenylacetatae (Ammonul®) and intravenous L-arginine.

Blood glucose levels should be monitored as these patients require a high rate of intravenous dextrose and intralipids with protein restriction. Additional medical stressors, such as infection or dehydration, should be diagnosed and treated.

If citrin deficiency with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is suspected, elevations of threonine may be found with an increased threonine/serine ratio and serum pancreatic secretory trypsin inhibitor. (Table 1 )

Table 1.

Test Results Indicative of the Disorder
Plasma amino acids Plasma amino acids Urine organic acids
Elevated Glutamine Elevated Citrulline Orotic acid present

Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?

The cause of elevations of ammonia must be carefully considered, as false-positive elevations are frequently seen. In addition, plasma ammonia must be placed in ice immediately after collection and then run as soon as possible or frozen within 15 minutes of blood draw.

Elevations of glutamine and alanine may be seen in other disorders with hyperammonemia. Other urea cycle disorders, including NAGS, CPS1, OTC, and ASA, will also have elevations of glutamine and alanine. Citrulline will be low in NAGS, CPS1, and OTC deficiencies. Arginine is low or normal in all urea cycle disorders, except ARG deficiency. Citrulline may only be moderately elevated in ASA deficiency. Argininosuccinic acid is only detected in ASA deficiency and may often coelute with leucine or isoleucine, requiring special sample preparation for accurate determination of ASA anhydrides.

Milder or later-onset forms may only show abnormalities of ammonia or plasma amino acids during acute exacerbations.

What Lab Results Are Absolutely Confirmatory?

Clinical history and elevations of citrulline and orotic acid are often sufficient for diagnosis. Confirmation of CIT1 should be performed through DNA sequencing of ASS or enzyme analysis.

Clinical testing of enzyme activity can be done from a fresh, frozen liver biopsy specimen or skin fibroblasts when confirmation is not possible through DNA sequence analysis.

What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?

Immediate and long-term testing and treatment is necessary to prevent morbidity and mortality in urea cycle disorders.

Confirmation of CIT1 is done through quantitative plasma amino acid analysis and urine organic acid analysis.

Follow-up long-term testing for the non-acutely ill patient should be include ongoing clinical management with regular monitoring of plasma amino acids, venous ammonia, and other clinical parameters, including a complete blood count (CBC), electrolytes, renal function testing, calcium, phosphorus, magnesium, and markers for liver disease (e.g., apartate aminotransferase, alanine aminotransferase, total and direct bilirubin, albumin, prealbumin, and coagulation parameters) and urinalysis should be checked and followed.

Dietary protein is important to ensure adequate growth and development. Over-restriction of protein may lead to increased metabolic stress and trigger a catabolic event and hyperammonemia.

Multiple vitamin and mineral deficiencies should also be carefully monitored.

Carnitine deficiency may also be found occasionally, and plasma total and free carnitine levels should be checked.

Long-term monitoring and follow-up should include such tests, along with trace minerals, zinc and selenium, and vitamins.

Affected individuals should have emergency plans in place for rapid measurement of ammonia and electrolytes to immediately implement treatment. Repeat diagnostic studies should also be collected if the diagnosis is uncertain in milder disease forms.

Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?

Results of the plasma amino acids, urine amino acids, and urine organic acids can be affected by the patient’s fasting status. If nonfasting or if the patient is receiving intravenous parental nutrition, test results may be difficult to interpret.

Urine amino acids are not able to provide sensitive quantitation of amino acids for confirmation of diagnosis. Repeat analysis at a recurrent event may be helpful along with additional diagnostic testing looking for other causes of hyperammonemia.

Clinical interpretation of abnormalities of glutamine, alanine, citrulline, arginine, and other amino acids is essential. It is often not possible to determine the significance without clinical information and additional diagnostic testing.

Isolated elevations of glutamine may be seen in other urea cycle disorders, liver disease, or any cause of hyperammonemia. Low glutamine levels often reflect improper sample handling.

Elevations of alanine may be seen in acute illness, with elevations of lactic acid or with prolonged fasting. If seen with an elevated proline level, there is a higher suspicion for a primary lactic acidosis, such as pyruvate dehydrogenase complex deficiency or mitochondrial disorders.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs